CDH17 and neuroendocrine neoplasm: Furthermore, CDH17 chimeric antigen receptor T cells have also been found to effectively eradicate CDH17-expressing neuroendocrine tumors and gastric, pancreatic and CRCs in either tumor xenograft or autochthonous mouse models (45).